DNA CONTENT IN CERVICAL-CARCINOMA - A FLOW CYTOMETRIC ASSESSMENT OF DNA HETEROGENEITY

被引:5
作者
CHANG, AR
GRIGNON, DJ
KEENEY, MM
KOSTER, JL
KIRK, ME
机构
[1] VICTORIA HOSP,DEPT PATHOL,LONDON N6A 4G5,ON,CANADA
[2] UNIV WESTERN ONTARIO,LONDON,ON,CANADA
[3] UNIV OTAGO,SCH MED,DEPT PATHOL,DUNEDIN,NEW ZEALAND
[4] VICTORIA HOSP,DEPT HEMATOL,LONDON N6A 4G5,ON,CANADA
关键词
CERVIX CARCINOMA; DNA CONTENT; FLOW CYTOMETRY;
D O I
10.1097/00004347-199410000-00006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The degree of DNA heterogeneity varies between tumors arising in different body sites. Any substantial degree of variability within a given tumor can give rise to significant problems in the interpretation of DNA flow cytometric (FCM) studies. This study was undertaken to evaluate the degree of DNA heterogeneity in cervical carcinomas. A total of 100 3-mm punch biopsies were evaluated from single large cases in 10 sections of cervical carcinoma. Of the 10 tumors, 6 were squamous carcinoma, 1 was an adenocarcinoma, 1 was a mixed small cell and squamous carcinoma, 1 was an adenosquamous cancer, and I was a small cell carcinoma with a small area of adenocarcinoma. Adequate histograms were available for 95 (95%) of the samples. Of the 10 cases studied, 9 (90%) revealed homogeneity in the DNA pattern. A solitary case demonstrated heterogeneity in one histogram (nine samples DNA diploid and one sample DNA aneuploid). This case was predominantly small cell undifferentiated carcinoma with focal adenocarcinoma. The area of adenocarcinoma was probably the area that contributed to the heterogeneous FCM pattern. From this study we conclude that for most cervical carcinomas of a specific histologic type there is DNA homogeneity. However, for carcinomas with a mixed morphology, DNA heterogeneity is possible and this must be taken into account in any DNA ploidy studies that include mixed or combined tumors.
引用
收藏
页码:330 / 336
页数:7
相关论文
共 43 条
[1]   NONRANDOM CHROMOSOME CHANGES IN CARCINOMA OF THE CERVIX UTERI .1. 9 NEAR-DIPLOID TUMORS [J].
ATKIN, NB ;
BAKER, MC .
CANCER GENETICS AND CYTOGENETICS, 1982, 7 (03) :209-222
[2]  
ATKIN NB, 1984, ADV CLIN CYTOLOGY, V2, P103
[3]  
BEERMAN H, 1991, CYTOMETRY, V12, P147, DOI 10.1002/cyto.990120208
[4]   DNA PLOIDY PROFILES AS PROGNOSTIC INDICATORS IN CIN LESIONS [J].
BIBBO, M ;
DYTCH, HE ;
ALENGHAT, E ;
BARTELS, PH ;
WIED, GL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 92 (03) :261-265
[5]  
CAREY FA, 1990, CANCER, V65, P2266, DOI 10.1002/1097-0142(19900515)65:10<2266::AID-CNCR2820651018>3.0.CO
[6]  
2-R
[7]  
CHIECO P, 1991, CANCER, V67, P1878, DOI 10.1002/1097-0142(19910401)67:7<1878::AID-CNCR2820670711>3.0.CO
[8]  
2-S
[9]  
CHUNG CK, 1981, OBSTET GYNECOL, V57, P636
[10]  
DEARETXABALA X, 1989, CANCER, V63, P791, DOI 10.1002/1097-0142(19890215)63:4<791::AID-CNCR2820630431>3.0.CO